The producers of two Covid-19 vaccines developed by Chinese pharmaceutical company Sinovac and Oxford-AstraZeneca submitted the first applications Friday for regulatory approval in hard-hit Brazil, officials said.
Federal health regulator Anvisa now has 10 days to respond to the applications, though it said that could include asking the sponsors to find out more.
One application was sent by the Butantan Institute, a public health center in Sao Paulo that is dealing with Sinovac to check and produce its CoronaVac vaccine.
The other was from the Fiocruz Structure, which is based in Rio de Janeiro and is dealing with the University of Oxford and its partner, the British-Swedish pharmaceutical firm AstraZeneca, in a similar partnership.
The applications came a day after authorities announced CoronaVac had shown efficiency of 78 percent in clinical trials in Brazil, news that Sao Paulo Guv Joao Doria called “historic.”.
Sinovac has not yet launched around the world arise from the final stage of scientific trials, which are likewise being carried out in Chile, Indonesia and Turkey.
As for the Oxford vaccine, results published in December found it was 62 percent efficient for volunteers given 2 full doses and 90 percent reliable for those offered a half dosage followed by a full dose.
However both vaccines seem except the more than 90 percent effectiveness reported for the vaccines from United States pharmaceutical companies Pfizer and Moderna.
Sao Paulo Governor Joao Doria shows a bundle of the CoronaVac vaccine– the Butantan Institute announced it had an efficiency of 78% against Covid-19 AFP/ NELSON ALMEIDA.
The CoronaVac and Oxford vaccines have been captured up in a political fight in Brazil in between Doria and far-right President Jair Bolsonaro, most likely challengers in governmental elections next year.
The federal government at first handed down CoronaVac, which Bolsonaro has actually derided as “Joao Doria’s Chinese vaccine.”.
But after having a hard time to protect adequate doses for Brazil’s population of 212 million, the health ministry revealed Thursday it had signed a handle the Butantan Institute for 100 million doses of the vaccine for use nationwide.
Fiocruz for its part prepares to import 2 million dosages of the AstraZeneca jab produced by India’s Serum Institute, the world’s biggest producer of vaccines by volume.
On Friday, Bolsonaro sent out a letter to Indian Prime Minister Narendra Modi in which “he urgently asked for the supply of the two million dosages” of the AstraZeneca jab.
The early delivery would enable the immediate application of the vaccination program, Bolsonaro said.
Brazil has the second-highest death toll in the pandemic after the United States, with more than 200,000 people eliminated by Covid-19.
The federal government has yet to set a start date for its vaccination campaign, a delay that has actually drawn scathing criticism from Bolsonaro opponents.